1. Home
  2. CNTN vs VTIX Comparison

CNTN vs VTIX Comparison

Compare CNTN & VTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$3.02

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

VTIX

Virtuix Holdings Inc. Class A Common Stock

N/A

Current Price

$3.50

Market Cap

222.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTN
VTIX
Founded
2017
2013
Country
United States
United States
Employees
12
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
185.3M
222.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CNTN
VTIX
Price
$3.02
$3.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
751.3K
487.7K
Earning Date
05-13-2026
08-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.14
$3.00
52 Week High
$5.27
$9.00

Technical Indicators

Market Signals
Indicator
CNTN
VTIX
Relative Strength Index (RSI) 51.38 45.05
Support Level $3.04 $3.07
Resistance Level $3.82 $4.51
Average True Range (ATR) 0.34 0.45
MACD 0.01 0.05
Stochastic Oscillator 60.60 33.33

Price Performance

Historical Comparison
CNTN
VTIX

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About VTIX Virtuix Holdings Inc. Class A Common Stock

Virtuix Holdings Inc develops technologies for immersive virtual environments, including both simulated and real-world applications. It develops virtual reality hardware and software, including the Omni Pro, an omni-directional treadmill designed to allow users to walk and run in multiple directions inside video games and other virtual worlds. The company operates at the intersection of gaming, fitness, and enterprise virtual reality. It has commercialized three products. The company operates in a single operating segment: the design, development, marketing, and sale of omni-directional treadmills, accessories, and related services to consumer and commercial customers. It derives revenue through a combination of hardware sales and recurring software and service income.

Share on Social Networks: